Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease

NCT03696160 is registered in ClinicalTrials.gov with NEAT ID Foundation as lead sponsor.

NCT NCT03696160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03696160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients With Advanced HIV Disease
Lead sponsor
NEAT ID Foundation
Phase
Phase 3
Overall status
Completed
Start date
March 5, 2019
Completion date
June 17, 2024
Enrollment
447 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids